Tools | Bookmark & Share | Make MrWhy My Homepage
MrWhy.com
Go
MrWhy.com » Videos » Dr Michael Huo, University of Texas Southwestern Medical Center, USA
Dr Michael Huo, University of Texas Southwestern Medical Center, USA
Dr Michael Huo,  University of Texas Southwestern Medical Center, USA
Report
Dr Michael Huo, University of Texas Southwestern Medical Center, USA
Dr Michael Huo speaks at an EHA 2010 press conference about a phase III prospective study comparing the dabigatran etexilate 220mg with enoxaparin 40mg as treatments to prevent venous thromboembolism (VTE) after total hip replacement surgery. The study showed dabigatran etexilate was as effective as enoxaparin but importantly also reduced the number of blood clots and deaths from blood clots.
Channel: www.ecancer.tv
Category: Science
Video Length: 0
Date Found: August 03, 2010
Date Produced:
View Count: 0
 
MrWhy.com Special Offers
1
2
3
4
5
 
About Us: About MrWhy.com | Advertise on MrWhy.com | Contact MrWhy.com | Privacy Policy | MrWhy.com Partners
Answers: Questions and Answers | Browse by Category
Comparison Shopping: Comparison Shopping | Browse by Category | Top Searches
Shop eBay: Shop eBay | Browse by Category
Shop Amazon: Shop Amazon | Browse by Category
Videos: Video Search | Browse by Category
Web Search: Web Search | Browse by Searches
Copyright © 2011 MrWhy.com. All rights reserved.